Literature DB >> 10737749

Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.

Y C Kim1, X Ji, N Melman, J Linden, K A Jacobson.   

Abstract

No highly selective antagonists of the A(2B) adenosine receptor (AR) have been reported; however such antagonists have therapeutic potential as antiasthmatic agents. Here we report the synthesis of potent and selective A(2B) receptor antagonists. The structure-activity relationships (SAR) of 8-phenyl-1, 3-di-(n-propyl)xanthine derivatives in binding to recombinant human A(2B) ARs in HEK-293 cells (HEK-A(2B)) and at other AR subtypes were explored. Various amide derivatives of 8-[4-[[carboxymethyl]oxy]phenyl]-1,3-di-(n-propyl)xanthine, 4a, were synthesized. A comparison of aryl, alkyl, and aralkyl amides demonstrated that simple anilides, particularly those substituted in the para-position with electron-withdrawing groups, such as nitro, cyano, and acetyl, bind selectively to human A(2B) receptors in the range of 1-3 nM. The unsubstituted anilide 12 had a K(i) value at A(2B) receptors of 1.48 nM but was only moderately selective versus human A(1)/A(2A) receptors and nonselective versus rat A(1) receptors. Highly potent and selective A(2B) antagonists were a p-aminoacetophenone derivative 20 (K(i) value 1.39 nM) and ap-cyanoanilide 27 (K(i) value 1.97 nM). Compound 27 was 400-, 245-, and 123-fold selective for human A(2B) receptors versus human A(1)/A(2A)/A(3) receptors, respectively, and 8.5- and 310-fold selective versus rat A(1)/A(2A) receptors, respectively. Substitution of the 1,3-dipropyl groups with 1,3-diethyl offered no disadvantage for selectivity, and high affinities at A(2B) receptors were maintained. Substitution of the p-carboxymethyloxy group of 4a and its amides with acrylic acid decreased affinity at A(2B) receptors while increasing affinity at A(1) receptors. 1, 3-Di(cyclohexylmethyl) groups greatly reduced affinity at ARs, although the p-carboxymethyloxy derivative 9 was moderately selective for A(2B) receptors. Several selective A(2B) antagonists inhibited NECA-stimulated calcium mobilization in HEK-A(2B) cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737749      PMCID: PMC9364909          DOI: 10.1021/jm990421v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   8.039


  35 in total

1.  Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors.

Authors:  X D Ji; K A Jacobson
Journal:  Drug Des Discov       Date:  1999-11

Review 2.  Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.

Authors:  B B Fredholm; K Bättig; J Holmén; A Nehlig; E E Zvartau
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

3.  Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

Authors:  Y C Kim; M de Zwart; L Chang; S Moro; J K von Frijtag Drabbe Künzel; N Melman; A P IJzerman; K A Jacobson
Journal:  J Med Chem       Date:  1998-07-16       Impact factor: 7.446

Review 4.  Theophylline: recent advances in the understanding of its mode of action and uses in clinical practice.

Authors:  R Vassallo; J J Lipsky
Journal:  Mayo Clin Proc       Date:  1998-04       Impact factor: 7.616

5.  Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines.

Authors:  J W Daly; P Butts-Lamb; W Padgett
Journal:  Cell Mol Neurobiol       Date:  1983-03       Impact factor: 5.046

6.  Calculating the dissociation constant of an unlabeled compound from the concentration required to displace radiolabel binding by 50%.

Authors:  J Linden
Journal:  J Cyclic Nucleotide Res       Date:  1982

7.  A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists.

Authors:  M de Zwart; R Link; J K von Frijtag Drabbe Künzel; G Cristalli; K A Jacobson; A Townsend-Nicholson; A P IJzerman
Journal:  Nucleosides Nucleotides       Date:  1998-06

8.  125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.

Authors:  M E Olah; C Gallo-Rodriguez; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1994-05       Impact factor: 4.436

9.  Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine.

Authors:  T Björck; L E Gustafsson; S E Dahlén
Journal:  Am Rev Respir Dis       Date:  1992-05

10.  Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors.

Authors:  K A Jacobson; K L Kirk; W L Padgett; J W Daly
Journal:  J Med Chem       Date:  1985-09       Impact factor: 7.446

View more
  50 in total

1.  [3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.

Authors:  X Ji; Y C Kim; D G Ahern; J Linden; K A Jacobson
Journal:  Biochem Pharmacol       Date:  2001-03-15       Impact factor: 5.858

2.  Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.

Authors:  G W Sullivan; J M Rieger; W M Scheld; T L Macdonald; J Linden
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

Review 3.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

Review 4.  Recent developments in adenosine receptor ligands and their potential as novel drugs.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Biochim Biophys Acta       Date:  2010-12-23

5.  Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.

Authors:  Shantanu Pal; Won Jun Choi; Seung Ah Choe; Cara L Heller; Zhan-Guo Gao; Moshe Chinn; Kenneth A Jacobson; Xiyan Hou; Sang Kook Lee; Hea Ok Kim; Lak Shin Jeong
Journal:  Bioorg Med Chem       Date:  2009-03-25       Impact factor: 3.641

6.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

7.  Characterization of the A2B adenosine receptor from mouse, rabbit, and dog.

Authors:  John A Auchampach; Laura M Kreckler; Tina C Wan; Jason E Maas; Dharini van der Hoeven; Elizabeth Gizewski; Jayashree Narayanan; Garren E Maas
Journal:  J Pharmacol Exp Ther       Date:  2009-01-13       Impact factor: 4.030

8.  Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.

Authors:  Lak Shin Jeong; Shantanu Pal; Seung Ah Choe; Won Jun Choi; Kenneth A Jacobson; Zhan-Guo Gao; Athena M Klutz; Xiyan Hou; Hea Ok Kim; Hyuk Woo Lee; Sang Kook Lee; Dilip K Tosh; Hyung Ryong Moon
Journal:  J Med Chem       Date:  2008-09-24       Impact factor: 7.446

9.  Stimulation of adenosine A(2B) receptors induces interleukin-6 secretion in cardiac fibroblasts via the PKC-delta-P38 signalling pathway.

Authors:  Wei Feng; Yao Song; Chao Chen; Zhi Zhen Lu; Youyi Zhang
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

10.  Recent improvements in the development of A(2B) adenosine receptor agonists.

Authors:  Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Francesca Fruttarolo; Romeo Romagnoli; Delia Preti
Journal:  Purinergic Signal       Date:  2009-01-31       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.